Citigroup
XGN icon

Citigroup’s Exagen XGN Stock Holding History

Citigroup’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,044
Closed -$22.5K – 6527
2025
Q3 		$22.5K Buy
+2,044
New +$18.1K ﹤0.01% 4784
2025
Q1 		– Sell
-5,582
Closed -$22.9K – 6015
2024
Q4 		$22.9K Buy
+5,582
New +$20.1K ﹤0.01% 5253
2022
Q3 		– Sell
-92
Closed -$1K – 6375
2022
Q2 		$1K Sell
92
-834
-90% -$4.86K ﹤0.01% 6110
2022
Q1 		$7K Sell
926
-1,787
-66% -$15.4K ﹤0.01% 5707
2021
Q4 		$32K Buy
2,713
+1,630
+151% +$19.1K ﹤0.01% 5247
2021
Q3 		$15K Buy
1,083
+568
+110% +$7.55K ﹤0.01% 5361
2021
Q2 		$8K Buy
515
+197
+62% +$3.02K ﹤0.01% 5747
2021
Q1 		$6K Sell
318
-598
-65% -$10.7K ﹤0.01% 5864
2020
Q4 		$12K Buy
916
+686
+298% +$9.69K ﹤0.01% 6905
2020
Q3 		$3K Sell
230
-415
-64% -$5.34K ﹤0.01% 7244
2020
Q2 		$8K Sell
645
-330
-34% -$4.46K ﹤0.01% 7148
2020
Q1 		$16K Buy
975
+311
+47% +$6.17K ﹤0.01% 6833
2019
Q4 		$17K Buy
+664
New +$11.8K ﹤0.01% 7005

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citigroup's XGN Position: Q4 2025 in Review

Citigroup sold out of Exagen (XGN) in Q4 2025, closing a stake of 2,044 shares — an estimated $22.5K sold.

Citigroup first reported a position in XGN in Q4 2019 and held it in 13 quarters. The position peaked at $32K in Q4 2021. 80 funds tracked by Wall St. Rank hold XGN as of Q4 2025.

  • Citigroup reported no remaining Exagen position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 2,044 Exagen shares in Q4 2025, an estimated $22.5K.
  • Citigroup first reported a position in Exagen in Q4 2019 and held it in 13 quarters.
  • Citigroup's Exagen position peaked at $32K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Exagen as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.